Stay updated on Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page.

Latest updates to the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedA new revision tag 'Revision: v3.5.4' is now shown, replacing the prior 'Revision: v3.5.3'. This reflects an update to the page's underlying version and template, affecting only metadata rather than content.SummaryDifference0.1%

- Check26 days agoNo Change Detected
- Check40 days agoChange DetectedThe page revision indicator was updated from v3.5.2 to v3.5.3, reflecting a platform/version change rather than a change to the clinical study details.SummaryDifference0.1%

- Check47 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check76 days agoChange DetectedSite revision badge updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision label updated to v3.4.3. The previous version was v3.4.2.SummaryDifference0.1%

- Check112 days agoChange DetectedThe page shows a new site revision label Revision: v3.4.2 and removes older notices (v3.4.1 and the funding-lapse notice). This appears to be a routine site maintenance update without affecting the study content or available actions.SummaryDifference0.5%

Stay in the know with updates to Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combined with Azacitidine in Colorectal Cancer Clinical Trial page.